Oryzon Genomics SA
MAD:ORY

Watchlist Manager
Oryzon Genomics SA Logo
Oryzon Genomics SA
MAD:ORY
Watchlist
Price: 1.678 EUR -0.71% Market Closed
Market Cap: 110.4m EUR
Have any thoughts about
Oryzon Genomics SA?
Write Note

Wall Street
Price Targets

ORY Price Targets Summary
Oryzon Genomics SA

Wall Street analysts forecast ORY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ORY is 5.882 EUR with a low forecast of 2.02 EUR and a high forecast of 12.6 EUR.

Lowest
Price Target
2.02 EUR
20% Upside
Average
Price Target
5.882 EUR
251% Upside
Highest
Price Target
12.6 EUR
651% Upside
Oryzon Genomics SA Competitors:
Price Targets
1952
Everest Medicines Ltd
1% Downside
SBTX
SkinBioTherapeutics PLC
201% Upside
CDTX
Cidara Therapeutics Inc
46% Upside
145020
Hugel Inc
31% Upside
GLPG
Galapagos NV
40% Upside
KYMR
Kymera Therapeutics Inc
63% Upside
SKYE
Skye Bioscience Inc
481% Upside
ANAB
AnaptysBio Inc
70% Upside

Revenue
Forecast

Revenue Estimate
Oryzon Genomics SA

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Oryzon Genomics SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-47%
Average Miss

Net Income
Forecast

Net Income Estimate
Oryzon Genomics SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-44%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ORY's stock price target?
Price Target
5.882 EUR

According to Wall Street analysts, the average 1-year price target for ORY is 5.882 EUR with a low forecast of 2.02 EUR and a high forecast of 12.6 EUR.

Back to Top